Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Treasury Shares: 2020-2025

Historic Treasury Shares for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Sep 2025 value amounting to $6.2 million.

  • Arcutis Biotherapeutics' Treasury Shares fell 4.59% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year decrease of 4.59%. This contributed to the annual value of $6.1 million for FY2024, which is 106.69% up from last year.
  • Arcutis Biotherapeutics' Treasury Shares amounted to $6.2 million in Q3 2025, which was down 5.96% from $6.6 million recorded in Q2 2025.
  • Over the past 5 years, Arcutis Biotherapeutics' Treasury Shares peaked at $7.2 million during Q1 2025, and registered a low of $310,068 during Q1 2021.
  • Over the past 3 years, Arcutis Biotherapeutics' median Treasury Shares value was $6.2 million (recorded in 2025), while the average stood at $5.2 million.
  • As far as peak fluctuations go, Arcutis Biotherapeutics' Treasury Shares spiked by 370.33% in 2022, and later fell by 4.59% in 2025.
  • Over the past 5 years, Arcutis Biotherapeutics' Treasury Shares (Quarterly) stood at $335,196 in 2021, then soared by 370.33% to $1.6 million in 2022, then skyrocketed by 85.83% to $2.9 million in 2023, then spiked by 106.69% to $6.1 million in 2024, then declined by 4.59% to $6.2 million in 2025.
  • Its Treasury Shares stands at $6.2 million for Q3 2025, versus $6.6 million for Q2 2025 and $7.2 million for Q1 2025.